{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:43:10Z","timestamp":1769272990756,"version":"3.49.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671463"],"award-info":[{"award-number":["81671463"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871182"],"award-info":[{"award-number":["81871182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2020.00287","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T04:24:21Z","timestamp":1588911861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Cumulative Live Birth Rates After the First ART Cycle Using Flexible GnRH Antagonist Protocol vs. Standard Long GnRH Agonist Protocol: A Retrospective Cohort Study in Women of Different Ages and Various Ovarian Reserve"],"prefix":"10.3389","volume":"11","author":[{"given":"Wanlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengde","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xifeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s10815-018-1264-8","article-title":"The curious case of premature luteinization","volume":"35","author":"Kaponis","year":"2018","journal-title":"J Assist Reprod Gen"},{"key":"B2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/humupd\/dmt014","article-title":"Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles","volume":"19","author":"Venetis","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/S0140-6736(01)06797-6","article-title":"Gonadotropin-releasing-hormone-receptor antagonists","volume":"358","author":"Huirne","year":"2001","journal-title":"Lancet (London, England)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/humrep\/deh357","article-title":"Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF\/ICSI patients: antide and hormone levels","volume":"19","author":"Huirne","year":"2004","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2165\/00003495-200464030-00005","article-title":"Contemporary pharmacological manipulation in assisted reproduction","volume":"64","author":"Huirne","year":"2004","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0140-6736(84)92840-X","article-title":"Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins","volume":"2","author":"Porter","year":"1984","journal-title":"Lancet (London, England)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2174\/1389201017666160118103147","article-title":"Ovarian stimulation protocol in IVF: an up-to-date review of the literature","volume":"17","author":"Pacchiarotti","year":"2016","journal-title":"Curr Pharm Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7827-10-26","article-title":"GnRH agonist vs. GnRH antagonist in in vitro fertilization and embryo transfer (IVF\/ET)","volume":"10","author":"Depalo","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist vs. GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1093\/humrep\/13.11.3023","article-title":"The ganirelix dose-finding study group","volume":"13","year":"1998","journal-title":"Hum Reprod (Oxford, England)."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/humrep\/15.11.2333","article-title":"Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study","volume":"15","author":"Janssens","year":"2000","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"Cd001750","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"Cd001750","DOI":"10.1002\/14651858.CD001750.pub3","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/humupd\/dmr004","article-title":"GnRH antagonists are safer than agonists: an update of a cochrane review","volume":"17","author":"Al-Inany","year":"2011","journal-title":"Hum Reprod Update"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e91796","DOI":"10.1371\/journal.pone.0091796","article-title":"Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3109\/09513590.2012.736561","article-title":"Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis","volume":"29","author":"Xiao","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist vs. long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"B18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbmo.2014.05.007","article-title":"GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data","volume":"29","author":"Grow","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/humrep\/del150","article-title":"Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage","volume":"21","author":"Jauniaux","year":"2006","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1007\/s10815-019-01568-w","article-title":"The impact of peak estradiol during controlled ovarian stimulation on the cumulative live birth rate of IVF\/ICSI in non-PCOS patients","volume":"36","author":"Zhang","year":"2019","journal-title":"J Assist Reprod Genet."},{"key":"B21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1472-6483(10)60957-1","article-title":"GnRH antagonist in IVF poor-responder patients: results of a randomized trial","volume":"11","author":"Marci","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"B22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5653\/cerm.2011.38.4.228","article-title":"GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF\/ICSI","volume":"38","author":"Kim","year":"2011","journal-title":"Clin Exp Reprod Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist vs. long GnRH agonist protocol in poor IVF responders: a randomized clinical trial","volume":"166","author":"Prapas","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.fertnstert.2013.08.024","article-title":"The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"100","author":"Xiao","year":"2013","journal-title":"Fertil Steril"},{"key":"B25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","article-title":"Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria-the why","volume":"9","author":"Esteves","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/humupd\/dmy019","article-title":"Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis","volume":"24","author":"Alviggi","year":"2018","journal-title":"Hum Reprod Update"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH agonist long protocol vs. GnRH antagonist protocol for various aged patients with diminished ovarian reserve: a retrospective study","volume":"13","author":"Huang","year":"2018","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1093\/humrep\/deu090","article-title":"Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Broekmans","year":"2014","journal-title":"Hum Reprod (Oxford, England)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.fertnstert.2014.04.010","article-title":"Diminished ovarian reserve is the predominant risk factor for gonadotropin-releasing hormone antagonist failure resulting in breakthrough luteinizing hormone surges in in vitro fertilization cycles","volume":"102","author":"Reichman","year":"2014","journal-title":"Fertil Steril"},{"key":"B30","doi-asserted-by":"publisher","first-page":"c214","DOI":"10.1159\/000235241","article-title":"Cohort studies: prospective vs. retrospective","volume":"113","author":"Euser","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"B31","doi-asserted-by":"publisher","first-page":"Cd012103","DOI":"10.1002\/14651858.CD012103.pub2","article-title":"Interventions for the prevention of OHSS in ART cycles: an overview of cochrane reviews","volume":"1","author":"Mourad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0175985","DOI":"10.1371\/journal.pone.0175985","article-title":"Comparisons of GnRH antagonist protocol vs. GnRH agonist long protocol in patients with normal ovarian reserve: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T04:24:24Z","timestamp":1588911864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2020.00287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":32,"alternative-id":["10.3389\/fendo.2020.00287"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2020.00287","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"287"}}